{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T15:56:58Z","timestamp":1787846218926,"version":"build-2784847793"},"reference-count":48,"publisher":"Japanese Circulation Society","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Circ J"],"published-print":{"date-parts":[[2015]]},"DOI":"10.1253\/circj.cj-15-0526","type":"journal-article","created":{"date-parts":[[2015,7,21]],"date-time":"2015-07-21T22:04:15Z","timestamp":1437516255000},"page":"1882-1890","source":"Crossref","is-referenced-by-count":60,"title":["Intestinal Immunity and Gut Microbiota as Therapeutic Targets for Preventing Atherosclerotic Cardiovascular Diseases"],"prefix":"10.1253","volume":"79","author":[{"given":"Tomoya","family":"Yamashita","sequence":"first","affiliation":[{"name":"Division of Cardiovascular Medicine, Department of Internal Medicine, Kobe University Graduate School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuyuki","family":"Kasahara","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Medicine, Department of Internal Medicine, Kobe University Graduate School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takuo","family":"Emoto","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Medicine, Department of Internal Medicine, Kobe University Graduate School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takuya","family":"Matsumoto","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Medicine, Department of Internal Medicine, Kobe University Graduate School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taiji","family":"Mizoguchi","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Medicine, Department of Internal Medicine, Kobe University Graduate School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoki","family":"Kitano","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Medicine, Department of Internal Medicine, Kobe University Graduate School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoto","family":"Sasaki","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Medicine, Department of Internal Medicine, Kobe University Graduate School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ken-ichi","family":"Hirata","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Medicine, Department of Internal Medicine, Kobe University Graduate School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"330","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Ridker PM, Danielson E, Fonseca FA, Genest J, Gotto AM Jr, Kastelein JJ, et al. Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. <i>N Engl J Med<\/i> 2008; 359: 2195\u20132207.","DOI":"10.1056\/NEJMoa0807646"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Zhang B, Kawachi E, Miura S, Uehara Y, Matsunaga A, Kuroki M, et al. Therapeutic approaches to the regulation of metabolism of high-density lipoprotein: Novel HDL-directed pharmacological intervention and exercise. <i>Circ J<\/i> 2013; 77: 2651\u20132663.","DOI":"10.1253\/circj.CJ-12-1584"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. De Rosa S, Curcio A, Indolfi C. Emerging role of microRNAs in cardiovascular diseases. <i>Circ J<\/i> 2014; 78: 567\u2013575.","DOI":"10.1253\/circj.CJ-14-0086"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Matsuzawa Y, Guddeti RR, Kwon TG, Lerman LO, Lerman A. Secondary prevention strategy of cardiovascular disease using endothelial function testing. <i>Circ J<\/i> 2015; 79: 685\u2013694.","DOI":"10.1253\/circj.CJ-15-0068"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Ketelhuth DF, Hansson GK. Modulation of autoimmunity and atherosclerosis: Common targets and promising translational approaches against disease. <i>Circ J<\/i> 2015; 79: 924\u2013933.","DOI":"10.1253\/circj.CJ-15-0167"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Ross R. Atherosclerosis: An inflammatory disease. <i>N Engl J Med<\/i> 1999; 340: 115\u2013126.","DOI":"10.1056\/NEJM199901143400207"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Libby P, Lichtman AH, Hansson GK. Immune effector mechanisms implicated in atherosclerosis: From mice to humans. <i>Immunity<\/i> 2013; 38: 1092\u20131104.","DOI":"10.1016\/j.immuni.2013.06.009"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Libby P. Mechanisms of acute coronary syndromes and their implication for therapy. <i>N Engl J Med<\/i> 2013; 368: 2004\u20132013.","DOI":"10.1056\/NEJMra1216063"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. McNelis JC, Olefsky JM. Macrophages, immunity, and metabolic disease. <i>Immunity<\/i> 2014; 41: 36\u201348.","DOI":"10.1016\/j.immuni.2014.05.010"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Kita T, Yamashita T, Sasaki N, Kasahara K, Sasaki Y, Yodoi K, et al. Regression of atherosclerosis with anti-CD3 antibody via augmenting a regulatory T-cell response in mice. <i>Cardiovsac Res<\/i> 2014; 102: 107\u2013117.","DOI":"10.1093\/cvr\/cvu002"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Nakajima K, Yamashita T, Kita T, Takeda M, Sasaki N, Kasahara K, et al. Orally administered eicosapentaenoic acid induces rapid regression of atherosclerosis via modulating the phenotype of dendritic cells in LDL receptor-deficient mice. <i>Arterioscler Thromb Vasc Biol<\/i> 2011; 31: 1963\u20131972.","DOI":"10.1161\/ATVBAHA.111.229443"},{"key":"12","doi-asserted-by":"publisher","unstructured":"12. Kasahara K, Sasaki N, Yamashita T, Kita T, Yodoi K, Sasaki Y, et al. CD3 antibody and IL-2 complex combination therapy inhibits atherosclerosis by augmenting a regulatory immune response. <i>J Am Heart Assoc<\/i> 2014; 3: e000719, doi:10.1161\/JAHA.113.000719.","DOI":"10.1161\/JAHA.113.000719"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Sasaki N, Yamashita T, Takeda M, Shinohara M, Nakajima K, Tawa H, et al. Oral anti-CD3 antibody treatment induces regulatory T cells and inhibits the development of atherosclerosis in mice. <i>Circulation<\/i> 2009; 120: 1996\u20132005.","DOI":"10.1161\/CIRCULATIONAHA.109.863431"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Takeda M, Yamashita T, Sasaki N, Nakajima K, Kita T, Shinohara M, et al. Oral administration of an active form of vitamin D3 (calcitriol) decreases atherosclerosis in mice by inducing regulatory T cells and immature dendritic cells with tolerogenic functions. <i>Arterioscler Thromb Vasc Biol<\/i> 2010; 30: 2495\u20132503.","DOI":"10.1161\/ATVBAHA.110.215459"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Human Microbiome Project Consortium. Structure, function and diversity of the healthy human microbiome. <i>Nature<\/i> 2012; 486: 207\u2013214.","DOI":"10.1038\/nature11234"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Qin J, Li R, Raes J, Arumugam M, Burgdorf KS, Manichanh C, et al. A human gut microbial gene catalogue established by metagenomic sequencing. <i>Nature<\/i> 2010; 464: 59\u201365.","DOI":"10.1038\/nature08821"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Dalal SR, Chang EB. The microbial basis of inflammatory bowel diseases. <i>J Clin Invest<\/i> 2014; 124: 4190\u20134196.","DOI":"10.1172\/JCI72330"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Weiner HL, da Cunha AP, Quintana F, Wu H. Oral tolerance. <i>Immunol Rev<\/i> 2011; 241: 241\u2013259.","DOI":"10.1111\/j.1600-065X.2011.01017.x"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Chen W, Jin W, Hardegen N, Lei KJ, Li L, Marinos N, et al. Conversion of peripheral CD4<sup>+<\/sup>CD25<sup>\u2212<\/sup> naive T cells to CD4<sup>+<\/sup>CD25<sup>+<\/sup> regulatory T cells by TGF-beta induction of transcription factor Foxp3. <i>J Exp Med<\/i> 2003; 198: 1875\u20131886.","DOI":"10.1084\/jem.20030152"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Ochi H, Abraham M, Ishikawa H, Frenkel D, Yang K, Basso AS, et al. Oral CD3-specific antibody suppresses autoimmune encephalomyelitis by inducing CD4<sup>+<\/sup> CD25<sup>\u2212<\/sup> LAP<sup>+<\/sup> T cells. <i>Nat Med<\/i> 2006; 12: 627\u2013635.","DOI":"10.1038\/nm1408"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Ishikawa H, Ochi H, Chen ML, Frenkel D, Maron R, Weiner HL. Inhibition of autoimmune diabetes by oral administration of anti-CD3 monoclonal antibody. <i>Diabetes<\/i> 2007; 56: 2103\u20132109.","DOI":"10.2337\/db06-1632"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Hermansson A, Johansson DK, Ketelhuth DF, Andersson J, Zhou X, Hansson GK. Immunotherapy with tolerogenic apolipoprotein B-100-loaded dendritic cells attenuates atherosclerosis in hypercholesterolemic mice. <i>Circulation<\/i> 2011; 123: 1083\u20131091.","DOI":"10.1161\/CIRCULATIONAHA.110.973222"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Maron R, Sukhova G, Faria AM, Hoffmann E, Mach F, Libby P, et al. Mucosal administration of heat shock protein-65 decreases atherosclerosis and inflammation in aortic arch of low-density lipoprotein receptor-deficient mice. <i>Circulation<\/i> 2002; 106: 1708\u20131715.","DOI":"10.1161\/01.CIR.0000029750.99462.30"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Arumugam M, Raes J, Pelletier E, Le Paslier D, Yamada T, Mende DR, et al. Enterotypes of the human gut microbiome. <i>Nature<\/i> 2011; 473: 174\u2013180.","DOI":"10.1038\/nature09944"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Lozupone CA, Stombaugh JI, Gordon JI, Jansson JK, Knight R. Diversity, stability and resilience of the human gut microbiota. <i>Nature<\/i> 2012; 489: 220\u2013230.","DOI":"10.1038\/nature11550"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Littman DR, Rudensky AY. Th17 and regulatory T cells in mediating and restraining inflammation. <i>Cell<\/i> 2010; 140: 845\u2013858.","DOI":"10.1016\/j.cell.2010.02.021"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Atarashi K, Tanoue T, Oshima K, Suda W, Nagano Y, Nishikawa H, et al. Treg induction by a rationally selected mixture of Clostridia strains from the human microbiota. <i>Nature<\/i> 2013; 500: 232\u2013236.","DOI":"10.1038\/nature12331"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Atarashi K, Tanoue T, Shima T, Imaoka A, Kuwahara T, Momose Y, et al. Induction of colonic regulatory T cells by indigenous Clostridium species. <i>Science<\/i> 2011; 331: 337\u2013341.","DOI":"10.1126\/science.1198469"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Furusawa Y, Obata Y, Fukuda S, Endo TA, Nakato G, Takahashi D, et al. Commensal microbe derived butyrate induces the differentiation of colonic regulatory T cells. <i>Nature<\/i> 2013; 504: 446\u2013450.","DOI":"10.1038\/nature12721"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Backhed F, Ding H, Wang T, Hooper LV, Koh GY, Nagy A, et al. The gut microbiota as an environmental factor that regulates fat storage. <i>Proc Natl Acad Sci USA<\/i> 2004; 101: 15718\u201315723.","DOI":"10.1073\/pnas.0407076101"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31. Turnbaugh PJ, Hamady M, Yatsunenko T, Cantarel BL, Duncan A, Ley RE, et al. A core gut microbiome in obese and lean twins. <i>Nature<\/i> 2009; 457: 480\u2013484.","DOI":"10.1038\/nature07540"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32. Le Chatelier E, Nielsen T, Qin J, Prifti E, Hildebrand F, Falony G, et al. Richness of human gut microbiome correlates with metabolic markers. <i>Nature<\/i> 2013; 500: 541\u2013546.","DOI":"10.1038\/nature12506"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33. Ley RE, Turnbaugh PJ, Klein S, Gordon JI. Microbial ecology: Human gut microbes associated with obesity. <i>Nature<\/i> 2006; 444: 1022\u20131023.","DOI":"10.1038\/4441022a"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34. Turnbaugh PJ, Ley RE, Mahowald MA, Magrini V, Mardis ER, Gordon JI. An obesity-associated gut microbiome with increased capacity for energy harvest. <i>Nature<\/i> 2006; 444: 1027\u20131031.","DOI":"10.1038\/nature05414"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35. Frost G, Sleeth ML, Sahuri-Arisoylu M, Lizarbe B, Cerdan S, Brody L, et al. The short-chain fatty acid acetate reduces appetite via a central homeostatic mechanism. <i>Nat Commun<\/i> 2014; 5: 3611.","DOI":"10.1038\/ncomms4611"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36. Qin J, Li Y, Cai Z, Li S, Zhu J, Zhang F, et al. A metagenome-wide association study of gut microbiota in type 2 diabetes. <i>Nature<\/i> 2012; 490: 55\u201360.","DOI":"10.1038\/nature11450"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37. Karlsson FH, Tremaroli V, Nookaew I, Bergstr\u00f6m G, Behre CJ, Fagerberg B, et al. Gut metagenome in European women with normal, impaired and diabetic glucose control. <i>Nature<\/i> 2013; 498: 99\u2013103.","DOI":"10.1038\/nature12198"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38. Sato J, Kanazawa A, Ikeda F, Yoshihara T, Goto H, Abe H, et al. Gut dysbiosis and detection of \u201clive gut bacteria\u201d in blood of Japanese patients with type 2 diabetes. <i>Diabetes Care<\/i> 2014; 37: 2343\u20132350.","DOI":"10.2337\/dc13-2817"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39. Wright SD, Burton C, Hernandez M, Hassing H, Montenegro J, Mundt S, et al. Infectious agents are not necessary for murine atherogenesis. <i>J Exp Med<\/i> 2000; 191: 1437\u20131442.","DOI":"10.1084\/jem.191.8.1437"},{"key":"40","doi-asserted-by":"crossref","unstructured":"40. Stepankova R, Tonar Z, Bartova J, Nedorost L, Rossman P, Poledne R, et al. Absence of microbiota (germ-free conditions) accelerates the atherosclerosis in ApoE-deficient mice fed standard low cholesterol diet. <i>J Atheroscler Thromb<\/i> 2010; 17: 796\u2013804.","DOI":"10.5551\/jat.3285"},{"key":"41","doi-asserted-by":"crossref","unstructured":"41. Velagapudi VR, Hezaveh R, Reigstad CS, Gopalacharyulu P, Yetukuri L, Islam S, et al. The gut microbiota modulates host energy and lipid metabolism in mice. <i>J Lipid Res<\/i> 2010; 51: 1101\u20131112.","DOI":"10.1194\/jlr.M002774"},{"key":"42","doi-asserted-by":"crossref","unstructured":"42. Karlsson FH, Fak F, Nookaew I, Tremaroli V, Fagerberg B, Petranovic D, et al. Symptomatic atherosclerosis is associated with an altered gut metagenome. <i>Nat Commun<\/i> 2012; 3: 1245.","DOI":"10.1038\/ncomms2266"},{"key":"43","doi-asserted-by":"crossref","unstructured":"43. Wang Z, Klipfell E, Bennett BJ, Koeth R, Levison BS, Dugar B, et al. Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease. <i>Nature<\/i> 2011; 472: 57\u201363.","DOI":"10.1038\/nature09922"},{"key":"44","doi-asserted-by":"crossref","unstructured":"44. Tang WH, Wang Z, Levison BS, Koeth RA, Britt EB, Fu X, et al. Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk. <i>N Engl J Med<\/i> 2013; 368: 1575\u20131584.","DOI":"10.1056\/NEJMoa1109400"},{"key":"45","doi-asserted-by":"crossref","unstructured":"45. Koeth RA, Wang Z, Levison BS, Buffa JA, Org E, Sheehy BT, et al. Intestinal microbiota metabolism of L-carnitine, a nutrient in red meat, promotes atherosclerosis. <i>Nat Med<\/i> 2013; 19: 576\u2013585.","DOI":"10.1038\/nm.3145"},{"key":"46","doi-asserted-by":"crossref","unstructured":"46. Koeth RA, Levison BS, Culley MK, Buffa JA, Wang Z, Gregory JC, et al. \u03b3-butyrobetaine is a proatherogenic intermediate in gut microbial metabolism of L-carnitine to TMAO. <i>Cell Metab<\/i> 2014; 20: 799\u2013812.","DOI":"10.1016\/j.cmet.2014.10.006"},{"key":"47","doi-asserted-by":"crossref","unstructured":"47. van Nood E, Vrieze A, Nieuwdorp M, Fuentes S, Zoetendal EG, de Vos WM, et al. Duodenal infusion of donor feces for recurrent Clostridium difficile. <i>N Engl J Med<\/i> 2013; 368: 407\u2013415.","DOI":"10.1056\/NEJMoa1205037"},{"key":"48","doi-asserted-by":"publisher","unstructured":"48. Vrieze A, Van Nood E, Holleman F, Saloj\u00e4rvi J, Kootte RS, Bartelsman JF, et al. Transfer of intestinal microbiota from lean donors increases insulin sensitivity in individuals with metabolic syndrome. <i>Gastroenterology<\/i> 2012; 143: 913\u2013916.e7, doi:10.1053\/j.gastro.2012.06.031.","DOI":"10.1053\/j.gastro.2012.06.031"}],"container-title":["Circulation Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/circj\/advpub\/0\/advpub_CJ-15-0526\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,28]],"date-time":"2019-08-28T15:15:05Z","timestamp":1567005305000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/circj\/79\/9\/79_CJ-15-0526\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015]]},"references-count":48,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2015]]}},"URL":"https:\/\/doi.org\/10.1253\/circj.cj-15-0526","relation":{},"ISSN":["1346-9843","1347-4820"],"issn-type":[{"value":"1346-9843","type":"print"},{"value":"1347-4820","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015]]}}}